dr. bekaii saab compares toxicities of regorafenib and tas-102 in colorectal cancer
Published 7 years ago • 221 plays • Length 2:24Download video MP4
Download video MP3
Similar videos
-
2:22
dr. bekaii-saab on differences between regorafenib and tas-102 in crc
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
0:20
copy of dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
1:50
dr. bekaii-saab on sequencing regorafenib and tas-102 in crc
-
1:23
dr. bekaii-saab on benefits associated with regorafenib or tas-102 for crc
-
3:07
trifluridine/tipiracil: a review in metastatic gastric cancer
-
7:53
reversal of type - 2 diabetes - by dr. b. m. makkar.
-
3:09
pancreatic cancer: treatments, risks of surgery and risk minimization | prof buechler
-
0:57
choosing between tas-102 and regorafenib in colorectal cancer
-
4:19
the role of tas-102 in metastatic colorectal cancer
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
4:53
debate: salvage therapy for mcrc? - tas-102 followed by regorafenib
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
5:42
role of tas-102 (trifluridine/tipiracil) in advanced colorectal cancer
-
0:57
dr. bekaii-saab discusses the next steps with regorafenib in crc
-
9:06
debate: is there an optimal treatment for refractory colorectal cancer? - tas-102 or regorafenib
-
2:27
dr. bekaii-saab on the redos study in metastatic colorectal cancer
-
1:39
dr. bekaii-saab on dosing strategies with regorafenib in crc
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
7:54
regorafenib vs tas-102 salvage therapy
-
1:21
dr. bekaii-saab discusses regorafenib use in mcrc